Connect Biopharma Holdings Ltd
Research Connect Biopharma Holdings Ltd (CNTB) on Bullrun: market cap USD 149.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCNTB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 149.85M
- Financial periodFY2025
- RevenueUSD 64.00K
- Revenue growth-99.8%
- Net income-USD 55.48M
- Free cash flow-USD 51.64M
Valuation Snapshot
latest market cap is USD 149.85M.
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Frequently asked questions
What is Connect Biopharma Holdings Ltd's market cap?
Connect Biopharma Holdings Ltd's market capitalization is USD 149.85M.
What does Connect Biopharma Holdings Ltd do?
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive...